ISO 13485:2003 certification for Advanced Cell Diagnostics

Advanced Cell Diagnostics, Inc. (ACD), a global technology and market leader in in situ nucleic acid detection for life science research and clinical diagnostics, has been granted ISO 13485:2003 certification, an international quality standard for medical devices, paving a path for ACD to launch its CE marked diagnostic tests in Europe.

The International Organization for Standardization (ISO) is the world's largest developer and publisher of international standards for the implementation of quality management systems and various other technical and operational procedures. ACD's ISO 13485:2003 certification covers the design, development, production, and commercialization of ACD's proprietary RNAscope® product lines. Addressing a long-standing technological gap in the analysis of RNA, RNAscope has seen rapid adoption by both academic and industrial researchers since the beginning of its full commercialization in 2011. There is strong interest in moving RNAscope-based biomarker assays from research to the clinic. 

"ACD's vision is to make RNAscope the PCR equivalent for in situ nucleic acid detection and drive adoption of this technology in diagnostic tests," states Dr. Yuling Luo, President and CEO of ACD. "This ISO certification is the first step in our quality systems road map, which is designed to ensure that we supply products of the highest quality to our customers and provide a seamless path for our partners to translate scientific advances to patient benefits."

ACD's RNAscope technology is the first automated multiplex RNA in situ hybridization platform capable of detecting and quantifying biomarkers with single‐molecule sensitivity. Unlike "grind‐and‐bind" assays such as RT‐PCR requiring RNA extraction from tissues, RNAscope detects and localizes single RNA molecules in individual cells in intact tissues, enabling simultaneous molecular and histopathological analysis. Unlike immunohistochemistry (IHC) which is often limited by lack of quality antibodies and inapplicable to the large emerging class of non‐coding RNAs, RNAscope assays can be developed and validated in two weeks for virtually any gene in any genome regardless of coding potential. RNAscope assays can be performed manually or fully automated using standard automated slide staining instruments for IHC and ISH, allowing seamless integration of RNAscope into current clinical laboratory workflows.

 

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Advanced Cell Diagnostics. (2019, June 18). ISO 13485:2003 certification for Advanced Cell Diagnostics. News-Medical. Retrieved on October 15, 2024 from https://www.news-medical.net/news/20140811/ISO-134852003-certification-for-Advanced-Cell-Diagnostics.aspx.

  • MLA

    Advanced Cell Diagnostics. "ISO 13485:2003 certification for Advanced Cell Diagnostics". News-Medical. 15 October 2024. <https://www.news-medical.net/news/20140811/ISO-134852003-certification-for-Advanced-Cell-Diagnostics.aspx>.

  • Chicago

    Advanced Cell Diagnostics. "ISO 13485:2003 certification for Advanced Cell Diagnostics". News-Medical. https://www.news-medical.net/news/20140811/ISO-134852003-certification-for-Advanced-Cell-Diagnostics.aspx. (accessed October 15, 2024).

  • Harvard

    Advanced Cell Diagnostics. 2019. ISO 13485:2003 certification for Advanced Cell Diagnostics. News-Medical, viewed 15 October 2024, https://www.news-medical.net/news/20140811/ISO-134852003-certification-for-Advanced-Cell-Diagnostics.aspx.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New generation of RNAscope products for RNA-biomarker analysis in FFPE tissue released